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Abstract
Aim—To describe factors associated with pregnancy desire and dual method use among people 
living with HIV in clinical care in sub-Saharan Africa.
Design—Sexually active HIV-positive adults were enrolled in 18 HIV clinics in Kenya, Namibia 
and Tanzania. Demographic, clinical and reproductive health data were captured by interview and 
medical record abstraction. Correlates of desiring a pregnancy within the next 6 months, and dual 
method use [defined as consistent condom use together with a highly effective method of 
contraception (hormonal, intrauterine device (IUD), permanent)], among those not desiring 
pregnancy, were identified using logistic regression.
Results—Among 3375 participants (median age 37 years, 42% male, 64% on antiretroviral 
treatment), 565 (17%) desired a pregnancy within the next 6 months. Of those with no short-term 
fertility desire (n=2542), 686 (27%) reported dual method use, 250 (10%) highly effective 
contraceptive use only, 1332 (52%) condom use only, and 274 (11%) no protection. Respondents 
were more likely to desire a pregnancy if they were from Namibia and Tanzania, male, had a 
primary education, were married/cohabitating, and had fewer children. Factors associated with 
increased likelihood of dual method use included being female, being comfortable asking a partner 
to use a condom, and communication with a health care provider about family planning. 
Participants who perceived that their partner wanted a pregnancy were less likely to report dual 
method use.
Conclusions—There was low dual method use and low use of highly effective contraception. 
Contraceptive protection was predominantly through condom-only use. These findings 
demonstrate the importance of integrating reproductive health services into routine HIV care.
INTRODUCTION
High rates of unintended pregnancy and unmet need for contraception are well documented 
in sub-Saharan Africa within the general population and in people living with HIV 
(PLHIV).1–3 Safe and effective contraception has been identified as a primary strategy for 
prevention of vertical transmission of HIV through unintended pregnancies,4 and is also 
highly cost-effective.56 While comprehensive HIV care and treatment programmes have 
scaled up in sub-Saharan Africa over the past decade, reaching a significant proportion of 
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PLHIV, there has not been a corresponding increase in access to integrated family planning 
(FP) services within HIV care programmes, a service model which remains a challenge.7–10
PLHIV may have lower fertility desires compared to the general population,211–13 but there 
is also clear evidence that PLHIV continue to want children, especially those who are 
younger or report fewer children.14–17 Limited fertility desire among PLHIV has been 
associated with not feeling healthy enough to sustain a pregnancy, fears that pregnancy 
could hasten disease progression, and fears of transmission to infants or sex partners.1819 
Initiation of antiretroviral treatment (ART) improves the health and quality of life among 
PLHIV and may lead to increased sexual activity, reduced fears associated with transmitting 
HIV, and a renewed desire to have children.20 There is some evidence that ART increases 
the fertility of women living with HIV;1921 however, studies have not consistently shown 
that being on ART1222 or having a healthy CD4 cell count2324 are associated with a desire 
for fertility. Societal norms and cultural influences also play a large role in fertility desire 
among PLHIV,2325–28 with studies suggesting that societal and cultural pressures to have 
children may diminish the health concerns that PLHIV have regarding childbearing.1929
Evidence indicates a high unmet need for contraception in sub-Saharan Africa among 
PLHIV who wish to delay or stop childbearing.5630 In a cohort of Ugandan women, 17% 
became pregnant within 2 years of initiating ART, despite 93% not wanting or planning 
pregnancy. Only 14% were using a modern contraceptive.31 High rates of unintended 
pregnancy among women initiating ART have also been found in South Africa1932 and 
Rwanda.33
Most HIV care providers encourage condom use among PLHIV but few discuss the benefits 
of additional contraceptive methods.34 Male condom use alone is associated with a 1-year 
cumulative incidence of unintended pregnancy of about 18% for typical users.35 Other 
methods of contraception such as sterilisation, intrauterine devices (IUDs) and hormonal 
contraceptives are more effective, but do not protect against HIV transmission or acquisition 
of other sexually transmitted infections (STIs). Thus, using only condoms for dual 
protection against HIV/STIs and unintended pregnancy is not as reliable or effective as dual 
method use,38 which combines consistent condom use with a highly effective contraceptive 
method.36 However, studies indicate that fewer than 20% of PLHIV in sub-Saharan Africa 
report dual method use.33037
The primary aim of this study was to inform efforts to expand FP and safer pregnancy 
counselling to PLHIV attending HIV clinical care services in sub-Saharan Africa. The study 
identified the frequency of fertility desire and dual method use among men and women 
living with HIV attending care and treatment clinics in Kenya, Namibia and Tanzania, and 
factors associated with both outcomes.
METHODS
Study design
This article presents data from the baseline assessment of a cluster-randomised trial 
evaluating a clinic-based HIV prevention intervention. From October 2009 to June 2010, 
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3538 HIV-positive sexually active men and women attending 18 HIV care and treatment 
clinics in Kenya, Tanzania and Namibia enrolled in the ‘HIV Prevention for People Living 
with HIV/ AIDS: Evaluation of an Intervention Toolkit for HIV Care and Treatment 
Settings’ study. The intervention and sampling procedure for this study have been described 
previously.38 In brief, six clinics in each country were paired on key characteristics (e.g. 
patient volume, provider/patient ratio, services offered, etc.) and then randomly assigned to 
either intervention or to a control arm. At the intervention clinics, health care providers and 
lay counsellors were trained to provide a package of HIV prevention messages and services 
as part of the routine care offered to HIV-positive clients. At the comparison clinics, clients 
received standard care. Participant eligibility criteria included being HIV-positive, aged over 
18 years, sexually active in the past 3 months, attended the clinic at least twice and planning 
to attend for at least 1 year. Exclusion criteria included women who reported a current 
pregnancy or men who reported that their partner was pregnant. All eligible patients 
attending the study clinics during the recruitment period were screened for participation. All 
enrolled patients provided written informed consent in their local language.
Six Institutional Review Boards (IRBs) approved the protocol (Centers for Disease Control 
and Prevention, Columbia University, and IRBs in Kenya, Namibia, Tanzania and 
Zanzibar).
Measures
Data on outcomes and most potential correlates of those outcomes were collected via a 
structured questionnaire administered in the respondent’s language of choice upon 
enrolment in the study. Eligible participants were identified by research interviewers who 
completed all study procedures including screening, consent, enrolment, interviews and 
medical chart abstraction for clinical correlates. The primary outcomes were desire for 
pregnancy in the next 6 months and use of dual contraceptive method. For the first outcome, 
female participants were asked if they desired a pregnancy and male participants were asked 
if they desired their partner to become pregnant in the next 6 months. For the second 
outcome, dual method use was classified as the use of a hormonal, IUD or permanent 
method together with consistent condom use, defined as condom used at every sexual 
encounter over the past 3 months. Both men and women reported on the contraceptive used 
within the partnership. The accuracy and completeness of the ‘self-report’ measurement was 
contingent upon the level of the men’s knowledge of their partner’s use of woman-
controlled contraceptive methods.
Potential correlates included socio-demographic factors (age, education level, marital status, 
number of living children, and duration of partnership), health status (length of time since 
HIV diagnosis, most recent CD4 count, current ART status), health provider communication 
about FP and/or safe pregnancy in the past 6 months, perception of partner’s desire for 
pregnancy, comfort asking partner to use condoms, experience of intimate partner violence, 
HIV disclosure to partner (spouse, main or most recent partner), and knowledge of partner’s 
HIV status.
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Of the 3538 adults enrolled in the study, the analytic sample for fertility desire (n=3375) 
excluded women aged >49 years (the upper limit of reproductive age; n=63) and participants 
with missing data on pregnancy desire (n=100). The analytic sample for dual method use 
(n=2542) excluded women who desired a pregnancy (n=286) and men who desired their 
partner to become pregnant (n=279 men) because they would be likely to make 
contraceptive choices consistent with actively trying to become pregnant. In addition, 
women aged >49 years (n=63), participants with missing data on condom use (men, n=64; 
women, n=60), highly effective contraceptive methods (men, n=143; women, n=1), or 
whose data on pregnancy desire were missing (men, n=78; women, n=22) were excluded 
from the dual method analysis.
Descriptive statistics were computed for variables of interest overall and by gender. 
Correlates of both outcomes – fertility desire and dual method use – were assessed for the 
overall study population and for women and men separately using logistic regression models 
controlling for clustering of observations within clinics. The reference category for fertility 
desire was not wanting a pregnancy in the next 6 months. For the dual method analysis, the 
reference category included those not using dual methods (i.e. using condoms only, using 
any other method without condoms, or not using any method). Those with missing values 
for the outcome variables were compared to those included and no significant differences 
were observed. All variables of interest were entered in the multiple regression models, and 
variables were considered statistically significant at a p value less than 0.05. Analyses were 
conducted using SAS V.9.3 (SAS Institute Inc., Cary, NC, USA).
RESULTS
Study participants
Among the 3375 participants in the fertility desire analysis, 1406 (42%) were men, the mean 
age was 37 years [standard deviation=8], 63% were married/ cohabitating, and 69% reported 
having two or more children. Compared to women, men were more likely to be older, 
married/cohabitating, and to be on ART (Table 1). While a high proportion (83%) of 
participants reported HIV disclosure to partners, 32% reported a partner of unknown 
serostatus and this was more commonly reported among women than men (41% vs 20%; 
p<0.0001).
Frequency and correlates of fertility desire among men and women
Overall, 565 (17%) participants reported desiring a pregnancy within the next 6 months. In 
the full multivariable model (Table 2), respondents from Tanzania [adjusted odds ratio 
(AOR) 2.13, 95% confidence interval (CI) 1.55–2.93; p<0.0001) and Namibia (AOR 2.07, 
95% CI 1.46–2.93; p<0.0001) were twice as likely to desire a pregnancy compared to those 
in Kenya. In addition, participants who were married (AOR 2.14, 95% CI 1.41–3.25; 
p<0.0001), had fewer children (AORnone vs 4+ 10.24, 95% CI 6.87–15.26; AOR1 vs 4+ 4.81, 
95% CI 3.41–6.78; AOR2 vs 4+ 2.45, 95% CI 1.74–3.44; p<0.0001), and were in recent 
partnerships (AOR<1 year vs 4+ 1.51, 95% CI 1.04–2.18; AOR1 to <2 years vs 4+ 1.68, 95% CI 
1.20–2.35; p=0.02) were more likely to desire a pregnancy. Compared to men, women were 
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significantly less likely to desire a pregnancy in the next 6 months (AOR 0.56, 95% CI 
0.45–0.71; p<0.0001). Clinical characteristics – time since HIV diagnosis, CD4 status, and 
provider communication – were not associated with pregnancy desire.
In the gender-stratified models, country, being married, and having fewer children remained 
positively associated with pregnancy desire in women compared to men (Table 2). In 
addition, ART was associated with increased desire for pregnancy among women but not 
men (AOR 1.62, 95% CI 1.15–2.27; p=0.006). Other clinical characteristics were not 
associated with pregnancy desire.
Frequency and correlates of dual method use
Among the 2542 sexually active PLHIV not desiring a pregnancy in the next 6 months, 2268 
(89%) reported some type of contraceptive use. Only 27% reported dual method use, 10% 
reported a highly effective method of contraception only, and 52% reported condom use 
only (Tables 3 and 4). Injectables were the most commonly reported highly effective 
method, used alone or as part of dual method use. Reported condom use was significantly 
lower among those using highly effective contraception (73%) compared to those not using 
highly effective methods (83%; p<0.0001).
Men were more likely to report only condom use and less likely to report dual method or 
highly effective contraception compared to women (Table 3). Frequency of any 
contraceptive use was similar among Kenyan and Namibian participants (91% and 93%, 
respectively), but lower among Tanzanian participants (83%; Table 4). Condom-only use 
was reported by more than half of participants in all countries; dual method use was higher 
in Namibia (34%) and Kenya (28%) compared to Tanzania (19%; p<0.0001).
Among all participants, factors associated with a decreased odds of dual method use 
included older age (AOR 0.96, 95% CI 0.95–0.98; p=0.001), being separated/divorced 
compared to never married (AOR 0.62, 95% CI 0.39–0.97; p=0.04), having fewer living 
children (AORnone vs. 4+ 0.32, 95% CI 0.18–0.55; AOR1 vs. 4+ 0.65, 95% CI 0.47–0.91; 
p<0.0001), and reporting that their partner wants a pregnancy/child (AOR 1.51, 95% CI 
1.08–2.11; p<0.001) (Table 5). Women were more likely to report dual method use than 
men (AOR 1.54, 95% CI 1.21–1.97; p=0.001). Participants who reported being comfortable 
asking their partner to use a condom (AOR 3.58, 95% CI 2.04–6.25; p<0.0001) or who 
recently discussed family planning with a health care provider (AOR 1.37, 95% CI 1.10–
1.69; p=0.006) were also more likely to report dual method use. Education level, disclosure, 
partner’s HIV status, partner violence, and clinical factors (on ART, CD4 level) were not 
associated with dual method use.
In the gender-stratified models, country-level differences in dual method use were observed. 
Women in Tanzania were less likely (AOR 0.59, 95% CI 0.37–0.95; p<0.0001) to report 
dual method use compared to women in Kenya, while women in Namibia were more likely 
to report dual method use (AOR 2.78, 95% CI 1.68–4.61; p<0.0001). In addition, women 
who reported an HIV diagnosis in the past year were more likely to report dual method use 
compared to women who had known of their diagnosis for ≥3 years (AOR 1.45, 95% CI 
1.02–2.06; p<0.003). Among men, the strongest correlate of decreased odds of dual method 
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use was shorter duration of partnership (AOR<1 vs ≥4 years 0.43, 95% CI 0.17–1.12; 
AOR1-<2 vs ≥4 years 0.12, 95% CI 0.03–0.53; p=0.02).
DISCUSSION
This was one of the largest multi-country studies on pregnancy desires, and is among the 
first to examine dual contraceptive method use among HIV-positive men and women 
enrolled in HIV care in sub-Saharan Africa. These findings therefore provide important 
insights into the social and clinical correlates of reproductive health behaviours and the 
service needs of PLHIV attending HIV clinical care. Only 17% of participants reported 
desiring a pregnancy in the next 6 months, an estimate lower than other studies among 
PLHIV in sub-Saharan Africa including studies from Nigeria (63%), Tanzania (37%), 
Uganda (31%) and South Africa (29%),15–1739 but higher than estimates from Uganda (8%) 
and Rwanda (8%).3137 Significant correlates of fertility desire included being currently 
married, having fewer children, and being in a recent relationship. Other studies have also 
found that having fewer children1519222337 and duration of relationship16 were important 
predictors of fertility desire among PLHIV.
Providing safer conception and pregnancy counselling to PLHIV who currently desire a 
pregnancy is important to reduce the risk of horizontal transmission to partners as well as 
vertical transmission to infants.40 HIV care providers are uniquely placed to provide this 
information, given their frequent contact with patients over a long period of time. Providers 
can assess the reproductive desires and intentions of their patients and inform them about 
how to conceive safely.19 Safer pregnancy counselling should include messages on the 
importance of ART adherence as well as teaching couples about ovulation and timed 
intercourse during the most fertile period.40 Treating genital infections, ensuring the woman 
is healthy enough for pregnancy (e.g. high CD4 count, low viral load, no opportunistic 
infections), and verifying that the mother is on a non-teratogenic ARV regimen are 
important clinical interventions supporting safer pregnancy.3240 Unfortunately, studies 
indicate that providers have not received training on how to provide safer pregnancy 
counselling,40 and some have unsupportive attitudes toward fertility desires in HIV-positive 
patients.151941
While 83% of participants did not desire a pregnancy within the next 6 months, only 27% 
reported dual method use. This rate was high compared to studies in Rwanda (1%), Uganda 
(11%) and Zambia (18%),33037 but lower than in a study from South Africa (33%).21 
Although PLHIV already linked into the health care system should be able to access a full 
range of contraceptive methods, limited integration between HIV and FP services and HIV 
care providers’ focus on counselling around consistent condom use may lead to the low rates 
of dual method use observed in this and other studies. Efforts toward integrating FP 
counselling and services into HIV clinical care have improved uptake of dual method 
use,283242 but there are substantial barriers to FP/HIV integration such as different funding 
streams resulting in vertical programming both at the policy and clinic level, inadequate 
training of HIV providers in reproductive health and contraceptive method choice 
counselling, and restricted availability of contraceptives at HIV clinics.3443 Because condom 
use was lower among men and women using highly effective contraception, programmes 
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should also ensure that appropriate messages and access to condoms continue to be 
reinforced.
Several partner-related variables were significantly associated with fertility desire and dual 
method use. For example, duration of partnership was associated with both men’s fertility 
desire and dual method use. Similarly, comfort asking a partner to use condoms was 
associated with dual method use for both men and women. These findings highlight the need 
for couple-level interventions.4445 In Zambia, a video-based intervention tailored towards 
HIV-affected (serodiscordant or seroconcordant) couples led to a significant increase (from 
22% to over 90%) in the uptake of a highly effective contraceptive method.42
While no clinical factors – CD4 count, ART use, duration of HIV infection – were 
associated with dual method use, discussing family planning with a health provider was. 
This suggests that strengthening provider-initiated interventions promoting reproductive 
health counselling and providing integrated FP services could have significant impact on 
reducing unmet need for dual method use.
Finally, country-level differences were observed for both fertility desire and dual method 
use, suggesting that fertility desire and contraceptive use are influenced by cultural factors. 
Few studies looking at fertility desire and contraceptive use among PLHIV include 
consideration of culture,20 but in many African societies, having children is an imperative 
for both men and women and their social status is often tied to the number of children they 
have.1929 Programmes should balance acknowledging these influences with initiatives 
toward addressing the potential unmet need for safer pregnancy planning, which includes 
spacing or limiting fertility.
While this study has several important strengths, a few limitations should be noted. The 
condom use component of the dual method outcome was not assessed for levels of correct 
condom use, and being subject to social desirability bias, is likely to be overestimated. 
Conversely, bias toward underestimating dual method may also be a factor because many of 
the highly effective contraceptives are female-controlled and their use may be under-
reported by male respondents. Finally, fertility desire and fertility intentions were not 
measured as separate constructs, and some literature has shown these two constructs to be 
different.15
We found significant unmet reproductive health needs among PLHIV attending HIV clinical 
care. Respecting the sexual and reproductive health rights of PLHIV should include 
programme interventions that ensure that all HIV patients’ pregnancy desires are discussed 
as part of routine consultations. Couples who desire children should be offered counselling 
on safer conception and pregnancy, while couples wishing to delay or stop child-bearing 
should be counselled on the importance of dual method use and offered a broad range of 
contraceptive methods, and condoms. While recommendations around consistent and correct 
condom use are important, health care workers should be aware of the likelihood that 
patients who report consistent and correct condom use may not be adequately protected 
against unintended pregnancy. Furthermore, efforts to integrate FP services into HIV clinical 
care will require strong policy directives, collaboration and commitment between 
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policymakers within HIV and reproductive health programmes, and resources for 
implementation.
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• This study demonstrates significant unmet reproductive health needs among 
people living with HIV attending HIV clinical care.
• Characteristics of partner communication and perception of partner’s fertility 
desire were significantly associated with dual method use; men should be 
equally included in reproductive health counselling and decision-making 
regarding contraceptive use.
• HIV care providers are uniquely placed to provide reproductive health 
information, given their frequent contact with patients over a long period of 
time.
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Table 3
Gender distribution of reported condom and contraceptive method use among sexually active HIV-positive 
patients who do not desire a pregnancy in the next 6 months
Contraceptive method Overall (n=2542*) [n (%)] Female (n=1622) [n (%)] Male (n=920) [n (%)] p
Dual method 686 (27) 498 (31) 188 (20) <0.0001
Highly effective method only* 250 (10) 210 (13) 40 (4)
Condom only 1332 (52) 716 (44) 616 (67)
No method 274 (11) 198 (12) 76 (8)
Dual method use
 Condom+pill 117 (17) 67 (13) 50 (27) <0.0001
 Condom+injectable 381 (56) 303 (61) 78 (41)
 Condom+LAPM† 134 (20) 85 (17) 49 (26)
 Condom+multiple methods‡ 54 (8) 43 (9) 11 (6)
Highly effective method
 Pill 57 (23) 45 (21) 12 (30) 0.76
 Injectable 133 (53) 113 (54) 20 (50)
 LAPM† 40 (16) 34 (16) 6 (15)
 Multiple methods‡ 20 (8) 18 (9) 2 (5)
Unmet need for dual method 1856 (73) 1124 (69) 732 (80) <0.0001
N=3538 excluding those who desired a pregnancy (n=565); women aged >49 years (n=63); participants with missing data on contraceptive use 
(n=268); or missing data on pregnancy desire (n=100).
*
Highly effective methods included hormonal methods (pill, injectable, implant), intrauterine device or permanent.
†
LAPM, long-acting or permanent methods (implants, intrauterine device, tubal ligation, vasectomy).
‡
Multiple highly effective methods reported.
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Table 4
Country distribution of reported condom and contraceptive method use among sexually active HIV-positive 
patients who do not desire a pregnancy in the next 6 months
Contraceptive method Kenya (n=943) [n (%)] Namibia (n=811) [n (%)] Tanzania (n=788) [n (%)] p
Dual method 261 (28) 279 (34) 146 (19) <0.0001
Highly effective method only* 118 (13) 56 (7) 76 (10)
Condom only 479 (51) 419 (52) 434 (55)
No contraception, no protection 85 (9) 57 (7) 132 (17)
Dual method use
 Condom+pill 57 (22) 35 (13) 25 (17) <0.0001
 Condom+injectable 138 (53) 188 (67) 55 (38)
 Condom+LAPM† 62 (24) 30 (11) 42 (29)
 Condom+multiple methods‡ 4 (2) 26 (9) 24 (16)
Highly effective method
 Pill 39 (33) 4 (7) 14 (18) <0.0001
 Injectable 57 (48) 39 (70) 37 (49)
 LAPM† 20 (17) 4 (7) 16 (21)
 Multiple methods‡ 2 (2) 9 (16) 9 (12)
Unmet need for dual method 682 (72) 532 (66) 642 (81) <0.0001
*
Highly effective methods included hormonal methods (pill, injectable, implant), intrauterine device or permanent.
†
LAPM, long-acting or permanent methods (implants, intrauterine device, tubal ligation, vasectomy).
‡
Multiple highly effective methods reported.
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